Manufacturer record
Maxcel Life Care: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Maxcel Life Care (Maharashtra) was declared Not of Standard Quality in May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CFL2411001, Cefixime and Lactic Acid Bacillus Dispersible Tablets (Micoceff-LB 200 Tablets) (exp Oct 2026). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: Identification and Assay of Cefixime Trihydate and Lactic Acid Bacillus. Listed in the May 2025 alert.
Records by type
1 record linked to Maxcel Life Care in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefixime and Lactic Acid Bacillus Dispersible Tablets (Micoceff-LB 200 Tablets) | Batch CFL2411001Mfg Nov 2024 · Exp Oct 2026 | Identification and Assay of Cefixime Trihydate and Lactic Acid BacillusAssay | RDTL, ChandigarhCDSCO lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.